<unk>  is an asparginase that is FDA approved for the treatment of acute lymphoblastic leukemia (ALL) and acute lymphoblastic leukemia and hypersensitivity to asparaginase.   Common adverse reactions include allergic reactions (including anaphylaxis), central nervous system thrombosis, coagulopathy, elevated transaminases, hyperbilirubinemia, hyperglycemia, and pancreatitis.
Pegaspargase
Agalsidase beta
Brinase
Alglucerase
Laronidase
Glucarpidase
Isozyme
Idursulfase